Trialjectory
6 known investors
Find your way into Trialjectory
Leal Health (formerly TrialJectory) operates an AI-powered decision support platform that matches cancer patients to personalized treatment and clinical trial options based on their specific diagnosis. It serves cancer patients directly, offering a free service supported by a team of PhDs, MDs, nurses, and social workers, and also provides trial-matching tools for oncologists.
Investors · 6
ICONYC labsNew York · $500K – $1M
Insight PartnersNew York · $120M – $350M
TIA VenturesNew York City
Contour Venture Partnersreported · 2 sourcesNew York · $500K – $2M
JAL Ventures Ltd.reported · 2 sourcesHerzliya
Also in the syndicate · 1
Rho Capital
Funding
SEC filings, press & company announcements$20M disclosed across 1 round · 2022
- $20MSeries AFeb 2022 · 2 sources
Insight Partners (lead), Contour Venture Partners, JAL Ventures, Rho Capital, TIA Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Trialjectory do?
- Leal Health (formerly TrialJectory) operates an AI-powered decision support platform that matches cancer patients to personalized treatment and clinical trial options based on their specific diagnosis. It serves cancer patients directly, offering a free service supported by a team of PhDs, MDs, nurses, and social workers, and also provides trial-matching tools for oncologists.
- Who are Trialjectory's investors?
- Trialjectory's investors include ICONYC labs, Insight Partners, TIA Ventures, Contour Venture Partners, JAL Ventures Ltd..
- How much funding has Trialjectory raised?
- Trialjectory has disclosed $20M raised across 1 round.